These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 2716408)
21. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis. Mak SK; Lo KY; Lo MW; Chan SF; Tong GM; Wong PN; Wong AK Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916 [TBL] [Abstract][Full Text] [Related]
22. [Development of lupus nephritis in childhood]. Ghio L; Edefonti A; Cohen E; Giani M; Miglioli E; Bardare M Pediatr Med Chir; 1986; 8(3):325-8. PubMed ID: 3786194 [TBL] [Abstract][Full Text] [Related]
23. When a patient with known lupus nephritis has persistent proteinuria despite corticosteroids and immunosuppressive treatment can it be assumed that there is continuing disease activity or may it reflect irreparable glomerular damage? How can one be sure? Cameron JS Br J Rheumatol; 1990 Feb; 29(1):68. PubMed ID: 2306576 [No Abstract] [Full Text] [Related]
24. Pharmacotherapy of lupus nephritis: time for a consensus? Perysinaki G; Panagiotakis S; Bertsias G; Boumpas DT Expert Opin Pharmacother; 2008 Aug; 9(12):2099-115. PubMed ID: 18671465 [TBL] [Abstract][Full Text] [Related]
26. Update on immunosuppressive therapy in human and experimental glomerulonephritis. Jacquot C; Baran D; Vendeville B; Pelletier L; Druet P Adv Nephrol Necker Hosp; 1988; 17():77-99. PubMed ID: 3124553 [No Abstract] [Full Text] [Related]
27. [Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis]. Saracyn M; Korsak J; Wańkowicz Z Pol Merkur Lekarski; 2004 Aug; 17(98):162-4. PubMed ID: 15603328 [TBL] [Abstract][Full Text] [Related]
28. Management of lupus nephritis: an update. Houssiau FA J Am Soc Nephrol; 2004 Oct; 15(10):2694-704. PubMed ID: 15466274 [No Abstract] [Full Text] [Related]
30. Treatment for lupus nephritis: a revisit. Lai KN; Tang SC; Mok CC Nephrology (Carlton); 2005 Apr; 10(2):180-8. PubMed ID: 15877679 [TBL] [Abstract][Full Text] [Related]
31. [Corticosteroids administered in bolus in lupus nephropathy]. Smurra G; Quaranta G; Angiello G Ann Ital Med Int; 1986 Mar; 1(1):75-80. PubMed ID: 3275182 [No Abstract] [Full Text] [Related]
32. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis. Jedlickova H; Bohmová J; Sirotkova A Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028 [No Abstract] [Full Text] [Related]
33. The benefit of early treatment with immunosuppressive drugs in lupus nephritis. Esdaile JM; Joseph L; MacKenzie T; Kashgarian M; Hayslett JP J Rheumatol; 1995 Jun; 22(6):1211. PubMed ID: 7674262 [No Abstract] [Full Text] [Related]
35. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children. Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528 [TBL] [Abstract][Full Text] [Related]
36. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy. Barbano G; Gusmano R; Damasio B; Alpigiani MG; Buoncompagni A; Gattorno M; Perfumo F J Nephrol; 2002; 15(2):123-9. PubMed ID: 12018627 [TBL] [Abstract][Full Text] [Related]
38. [Survival of patients with diffuse glomerulonephritis in disseminated lupus erythematosus treated with a combination of anticoagulants, corticosteroids and immunosuppressants]. Belovezhdov N; Dimitrova V Vutr Boles; 1987; 26(1):21-7. PubMed ID: 3590722 [TBL] [Abstract][Full Text] [Related]
39. Studies of immunosuppressive drugs in the treatment of lupus nephritis. Klippel JH; Austin HA; Balow JE; leRiche NG; Steinberg AD; Plotz PH; Decker JL Rheum Dis Clin North Am; 1987 Apr; 13(1):47-56. PubMed ID: 3306824 [TBL] [Abstract][Full Text] [Related]